TGFB1 and neoplasm: Zebularine/PPD combinational therapy downregulates the level of TGF‐β and PD‐L1, reduces the proportion of pro‐tumour immune cells (M2, Tregs and MDSCs), suppresses tumour growth and relapse, and prevents metastasis.1